Analysis of the Neuroproteome Associated With Cell Therapy After Intranigral Grafting in a Mouse Model of Parkinson Disease

Advances in large-scale proteomics analysis have been very useful in understanding pathogenesis of diseases and elaborating therapeutic strategies. Proteomics has been employed to study Parkinson disease (PD); however, sparse studies reported proteome investigation after cell therapy approaches. In...

Full description

Bibliographic Details
Main Authors: Hassan Dakik, Sarah Mantash, Ali Nehme, Firas Kobeissy, Masoud Zabet-Moghaddam, Parvin Mirzaei, Yehia Mechref, Afsaneh Gaillard, Laetitia Prestoz, Kazem Zibara
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2021.621121/full
_version_ 1818651490086027264
author Hassan Dakik
Hassan Dakik
Sarah Mantash
Sarah Mantash
Ali Nehme
Ali Nehme
Firas Kobeissy
Masoud Zabet-Moghaddam
Parvin Mirzaei
Yehia Mechref
Afsaneh Gaillard
Laetitia Prestoz
Kazem Zibara
Kazem Zibara
author_facet Hassan Dakik
Hassan Dakik
Sarah Mantash
Sarah Mantash
Ali Nehme
Ali Nehme
Firas Kobeissy
Masoud Zabet-Moghaddam
Parvin Mirzaei
Yehia Mechref
Afsaneh Gaillard
Laetitia Prestoz
Kazem Zibara
Kazem Zibara
author_sort Hassan Dakik
collection DOAJ
description Advances in large-scale proteomics analysis have been very useful in understanding pathogenesis of diseases and elaborating therapeutic strategies. Proteomics has been employed to study Parkinson disease (PD); however, sparse studies reported proteome investigation after cell therapy approaches. In this study, we used liquid chromatography–tandem mass spectrometry and systems biology to identify differentially expressed proteins in a translational mouse model of PD after cell therapy. Proteins were extracted from five nigrostriatal-related brain regions of mice previously lesioned with 6-hydroxydopamine in the substantia nigra. Protein expression was compared in non-grafted brain to 1 and 7 days after intranigral grafting of E12.5 embryonic ventral mesencephalon (VM). We found a total of 277 deregulated proteins after transplantation, which are enriched for lipid metabolism, oxidative phosphorylation and PD, thus confirming that our animal model is similar to human PD and that the presence of grafted cells modulates the expression of these proteins. Notably, seven proteins (Acta1, Atp6v1e1, Eci3, Lypla2, Pip4k2a, Sccpdh, and Sh3gl2) were commonly down-regulated after engraftment in all studied brain regions. These proteins are known to be involved in the formation of lipids and recycling of dopamine (DA) vesicle at the synapse. Moreover, intranigral transplantation of VM cells decreased the expression of proteins related to oxidative stress, especially in the nigrostriatal pathway containing the DA grafted neurons. In the same regions, an up-regulation of several proteins including α-synuclein and tyrosine hydroxylase was observed, whereas expression of tetraspanin 7 was shut down. Overall, these results suggest that intranigral transplantation of VM tissue in an animal model of PD may induce a decrease of oxidative stress in the nigrostriatal pathway and a restoration of the machinery of neurotransmitters, particularly DA release to promote DA transmission through a decrease of D2 DA receptors endocytosis. Identification of new mechanistic elements involved in the nigrostriatal reconstruction process, using translational animal models and systems biology, is a promising approach to enhance the repair of this pathway in PD patients undergoing cell therapy.
first_indexed 2024-12-17T02:06:56Z
format Article
id doaj.art-be0717d17595484d8f43dd912137ce00
institution Directory Open Access Journal
issn 1662-453X
language English
last_indexed 2024-12-17T02:06:56Z
publishDate 2021-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj.art-be0717d17595484d8f43dd912137ce002022-12-21T22:07:40ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2021-03-011510.3389/fnins.2021.621121621121Analysis of the Neuroproteome Associated With Cell Therapy After Intranigral Grafting in a Mouse Model of Parkinson DiseaseHassan Dakik0Hassan Dakik1Sarah Mantash2Sarah Mantash3Ali Nehme4Ali Nehme5Firas Kobeissy6Masoud Zabet-Moghaddam7Parvin Mirzaei8Yehia Mechref9Afsaneh Gaillard10Laetitia Prestoz11Kazem Zibara12Kazem Zibara13ER045, PRASE, Lebanese University, Beirut, LebanonUniversité de Tours, Tours, FranceER045, PRASE, Lebanese University, Beirut, LebanonINSERM, Laboratoire de Neurosciences Expérimentales et Cliniques, Université de Poitiers, Poitiers, FranceER045, PRASE, Lebanese University, Beirut, LebanonMcGill University and Génome Québec Innovation Centre, McGill University, Montreal, QC, CanadaDepartment of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, Beirut, LebanonCenter for Biotechnology and Genomics, Texas Tech University, Lubbock, TX, United StatesCenter for Biotechnology and Genomics, Texas Tech University, Lubbock, TX, United StatesCenter for Biotechnology and Genomics, Texas Tech University, Lubbock, TX, United StatesINSERM, Laboratoire de Neurosciences Expérimentales et Cliniques, Université de Poitiers, Poitiers, FranceINSERM, Laboratoire de Neurosciences Expérimentales et Cliniques, Université de Poitiers, Poitiers, FranceER045, PRASE, Lebanese University, Beirut, LebanonDepartment of Biology, Faculty of Sciences-I, Lebanese University, Beirut, LebanonAdvances in large-scale proteomics analysis have been very useful in understanding pathogenesis of diseases and elaborating therapeutic strategies. Proteomics has been employed to study Parkinson disease (PD); however, sparse studies reported proteome investigation after cell therapy approaches. In this study, we used liquid chromatography–tandem mass spectrometry and systems biology to identify differentially expressed proteins in a translational mouse model of PD after cell therapy. Proteins were extracted from five nigrostriatal-related brain regions of mice previously lesioned with 6-hydroxydopamine in the substantia nigra. Protein expression was compared in non-grafted brain to 1 and 7 days after intranigral grafting of E12.5 embryonic ventral mesencephalon (VM). We found a total of 277 deregulated proteins after transplantation, which are enriched for lipid metabolism, oxidative phosphorylation and PD, thus confirming that our animal model is similar to human PD and that the presence of grafted cells modulates the expression of these proteins. Notably, seven proteins (Acta1, Atp6v1e1, Eci3, Lypla2, Pip4k2a, Sccpdh, and Sh3gl2) were commonly down-regulated after engraftment in all studied brain regions. These proteins are known to be involved in the formation of lipids and recycling of dopamine (DA) vesicle at the synapse. Moreover, intranigral transplantation of VM cells decreased the expression of proteins related to oxidative stress, especially in the nigrostriatal pathway containing the DA grafted neurons. In the same regions, an up-regulation of several proteins including α-synuclein and tyrosine hydroxylase was observed, whereas expression of tetraspanin 7 was shut down. Overall, these results suggest that intranigral transplantation of VM tissue in an animal model of PD may induce a decrease of oxidative stress in the nigrostriatal pathway and a restoration of the machinery of neurotransmitters, particularly DA release to promote DA transmission through a decrease of D2 DA receptors endocytosis. Identification of new mechanistic elements involved in the nigrostriatal reconstruction process, using translational animal models and systems biology, is a promising approach to enhance the repair of this pathway in PD patients undergoing cell therapy.https://www.frontiersin.org/articles/10.3389/fnins.2021.621121/fullproteomecell therapynigrostriatal pathwaytransplantationParkinson diseasesystems biology
spellingShingle Hassan Dakik
Hassan Dakik
Sarah Mantash
Sarah Mantash
Ali Nehme
Ali Nehme
Firas Kobeissy
Masoud Zabet-Moghaddam
Parvin Mirzaei
Yehia Mechref
Afsaneh Gaillard
Laetitia Prestoz
Kazem Zibara
Kazem Zibara
Analysis of the Neuroproteome Associated With Cell Therapy After Intranigral Grafting in a Mouse Model of Parkinson Disease
Frontiers in Neuroscience
proteome
cell therapy
nigrostriatal pathway
transplantation
Parkinson disease
systems biology
title Analysis of the Neuroproteome Associated With Cell Therapy After Intranigral Grafting in a Mouse Model of Parkinson Disease
title_full Analysis of the Neuroproteome Associated With Cell Therapy After Intranigral Grafting in a Mouse Model of Parkinson Disease
title_fullStr Analysis of the Neuroproteome Associated With Cell Therapy After Intranigral Grafting in a Mouse Model of Parkinson Disease
title_full_unstemmed Analysis of the Neuroproteome Associated With Cell Therapy After Intranigral Grafting in a Mouse Model of Parkinson Disease
title_short Analysis of the Neuroproteome Associated With Cell Therapy After Intranigral Grafting in a Mouse Model of Parkinson Disease
title_sort analysis of the neuroproteome associated with cell therapy after intranigral grafting in a mouse model of parkinson disease
topic proteome
cell therapy
nigrostriatal pathway
transplantation
Parkinson disease
systems biology
url https://www.frontiersin.org/articles/10.3389/fnins.2021.621121/full
work_keys_str_mv AT hassandakik analysisoftheneuroproteomeassociatedwithcelltherapyafterintranigralgraftinginamousemodelofparkinsondisease
AT hassandakik analysisoftheneuroproteomeassociatedwithcelltherapyafterintranigralgraftinginamousemodelofparkinsondisease
AT sarahmantash analysisoftheneuroproteomeassociatedwithcelltherapyafterintranigralgraftinginamousemodelofparkinsondisease
AT sarahmantash analysisoftheneuroproteomeassociatedwithcelltherapyafterintranigralgraftinginamousemodelofparkinsondisease
AT alinehme analysisoftheneuroproteomeassociatedwithcelltherapyafterintranigralgraftinginamousemodelofparkinsondisease
AT alinehme analysisoftheneuroproteomeassociatedwithcelltherapyafterintranigralgraftinginamousemodelofparkinsondisease
AT firaskobeissy analysisoftheneuroproteomeassociatedwithcelltherapyafterintranigralgraftinginamousemodelofparkinsondisease
AT masoudzabetmoghaddam analysisoftheneuroproteomeassociatedwithcelltherapyafterintranigralgraftinginamousemodelofparkinsondisease
AT parvinmirzaei analysisoftheneuroproteomeassociatedwithcelltherapyafterintranigralgraftinginamousemodelofparkinsondisease
AT yehiamechref analysisoftheneuroproteomeassociatedwithcelltherapyafterintranigralgraftinginamousemodelofparkinsondisease
AT afsanehgaillard analysisoftheneuroproteomeassociatedwithcelltherapyafterintranigralgraftinginamousemodelofparkinsondisease
AT laetitiaprestoz analysisoftheneuroproteomeassociatedwithcelltherapyafterintranigralgraftinginamousemodelofparkinsondisease
AT kazemzibara analysisoftheneuroproteomeassociatedwithcelltherapyafterintranigralgraftinginamousemodelofparkinsondisease
AT kazemzibara analysisoftheneuroproteomeassociatedwithcelltherapyafterintranigralgraftinginamousemodelofparkinsondisease